◆ 会议时间：2023年8月24日至26日
◆ 会议地点：巴西 伊瓜苏市

◆ 会议简介：

2023年第31届世界心血管和胸外科医师学会(WSCTS)大会/年会将于2023年8月24日至26日在巴西伊瓜苏市举行。WSCTS大会将为来自世界各国的领导者和参与者提供一个独特的探讨、交流与学习的平台，以期在心血管和胸外科各个领域达成共识。

世界心胸外科医师学会(WSCTS)成立于1990年，成立大会于1991年在泰国清迈举行。WSCTS是唯一真正的国际性心血管和胸外科学会，其基本理念是建立一个交流心胸外科领域宣临床护理和研究进展的国际论坛。未经许可禁止复制摘录转载本站任何内容(国际医学会议网lingyuint.com)

WSCTS 2023 - 31st Annual Congress of World Society of Cardiovascular and Thoracic Surgeons

Date: 24 - 26 August 2023
Venue: Iguana Falls, Brazil

摘要征文投稿：

CLICK TO SUBMIT

SUBMISSION OF ABSTRACTS

• Authors must use electronic submission ONLY.
• WSCTS is not responsible for work not submitted by the submission deadline.
• No new submissions may be added to the system after the posted deadline.
• Submissions must be submitted in their final form by the deadline to be considered for presentation.
• The submission deadline will be on May 15, 2023.

Abstracts will be published exactly as submitted. Proofread carefully to avoid errors.

• An author may not revise or resubmit a submission in order to make corrections after the submission deadline. Rather, the submission may be withdrawn or, if accepted, the error may be revised and indicated during the presentation.
• All expenses (e.g., registration, airfare, lodging, etc.) associated with the submission and presentation are the presenter's responsibility.
• Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to register for the activity and present the accepted work, if not justified, will jeopardize future acceptance of abstracts by the WSCTS, LACES, and SBSCVS.

ABSTRACT SUBMISSION POLICIES

Author Name(s)

• There is no limit to the number of abstracts an author may submit.
• There must be a minimum of two (2) authors on the abstract submission.
• There is no maximum number of authors that may be listed on the submission.
• All co-authors must be listed on the abstract submission.
• Authors do not need to be WSCTS members to participate.
• Additions or deletions of author names are not permitted after the submission deadline.
• If an author's name appears on more than one submission, it must be identical on each submission.
• The presenting author must be one of the co-authors listed on the submitted abstract.
• Suppose an author has more than one submission accepted for presentation. In that case, he/she may only present one submission personally and must assign one of his/her co-authors to present any subsequent abstracts.
• The submitting author must notify all co-authors that this work has been submitted

Format

• All abstracts must be structured using the following four section headings or they will not be considered. The labels must be submitted in bold font. Please see the sample abstract at the end of this document.
• Objective: The hypothesis tested or the purpose of the study.
• Methods: Details of the study design or protocol.
• Results: Results of the study with appropriate statistical inferences.
• Conclusions: Clinical importance and potential significance of findings.
• The text of your abstract must be less than 3,500 characters, including spaces (title, authors and institutions will not be counted).

Content

• Submissions containing identical or nearly identical data submitted from the same institution and/or authors will be disqualified.
• Authors should not split data to create several abstracts from one study, clinical trial, and/or experiment. If splitting is judged to have occurred, priority scores of all related abstracts will suffer, and abstracts may be disqualified.
• The use of tables or graphics are encouraged if they are relevant to the research submitted. You may include one table or one figure within your submission. Please be mindful that tables and graphics, if the quality submitted is poor, will appear badly in electronic publications.
• Abstracts should clearly reflect the content of the completed paper.
• The abstract should not use abbreviations, which are not commonly accepted within the cardiothoracic surgical literature. Commonly accepted abbreviations within the cardiothoracic surgical literature will be accepted (i.e. - CABG, FEV1, GERD, CPR). However, other medical acronyms (i.e. - bronchiolitis obliterans syndrome (BOS)) should be first spelled out.
• When percentages are used, the absolute numbers from which the fractions are derived must also be stated.
• The abstract language is English.

*Abstract submissions may be disqualified, sanctioned, and/or removed from the program if the policies listed above are not followed.

AUTHORS’ CONSENT AND WAIVER OF CLAIMS FOR ABSTRACT SUBMISSIONS

• Each author agrees they have read and consent to all rules and regulations as outlined, pertaining to the submission of abstracts. It is the responsibility of the author to be in accordance with these rules and regulations during all parts of, but not limited to, the abstract submission and review process.
• Upon submission, authors waive any and all claims against the WSCTS and any reviewer and/or Planning Committee Member pertaining to, but not limited to, the abstract submission and review process.

ABSTRACT REVIEW

• After the submission deadline, all abstracts are considered Complete and will be forwarded to review.
• Submissions with an Incomplete status after the submission deadline will not be considered for presentation.
• Submitted abstracts are peer-reviewed by a panel of graders. Grading is blinded and selections for presentation are based solely on scientific merit.

ABSTRACT NOTIFICATION

• Abstract notifications will be distributed to the submitting author via email. It is the responsibility of the submitting author to notify all co-authors of the decision.

ABSTRACT PRESENTATION

• All abstracts presented at WSCTS activities must conform to the eligibility criteria listed above.
• All presentations and questions-and-answer periods will be in English (unless otherwise instructed). If presenters need assistance in understanding or responding to questions in English, they are encouraged to have a member of their research group assist them.
• Each presenting author is required to be registered for the meeting. There should be one registration per abstract submitted. Failure to comply to this will disqualify the abstract.
• Disclosure information collected during the submission process will be published in WSCTS’s final program materials. To be in compliance with this policy, presenting authors must disclose at the beginning of their presentation.
• Any additional or revised guidelines for abstract presentation will be provided to presenting authors of accepted abstracts in their notification email.

This society, founded in 1990 by the pioneers of cardiac surgery, aims to bring together cardiovascular and thoracic surgeons worldwide in a forum for the exchange of ideas and progress in clinical care and research. The annual meetings are held in various parts of the world, with the congress participants enjoying different realities and experiences.

The 26th meeting was held in Cape Town, South Africa (2016), and the 27th in Astana, Kazakhstan (2017). The 2018 meeting was held in Ljubljana, Slovenia, the 2021 meeting was held in Sophia, Bulgaria, and the 2022 meeting was held from 15 to 18 September this year in St. Petersburg, Russia.

To host the 31st edition, Brazil was elected as the host country, and the city of Foz do Iguaçú was chosen. The city is known worldwide by the recognition of Iguassu Falls in 1986 by UNESCO as a Natural World Heritage Site and, in 2012, elected one of the 7 Natural Wonders of the World.

This congress will bring together the world's leading cardiovascular and thoracic surgeons, interacting with a large group of Brazilian surgeons in a three-day immersion consisting of lectures by guests and world leaders in their fields and selected international presentations of scientific papers.

We will have four auditoriums, interconnected by the exhibition area, which will have a preponderant role and will update the participants on the main benefits of its products and services. The hands-on sessions will be presented as a landmark, as experts from other countries will present their techniques so that they can be applied in our centers, and we will be able to offer our patients the best and most up-to-date.

The Congress of the World Society of Cardiovascular and Thoracic Surgery goes beyond the stage and intends to make a difference in the performance of those professionals who opt for this special meeting that will promote its significant update in 2023.

We remind you that with this event, we will have the first congress of Latin American surgeons, under the responsibility of LACES - Latin American Association of Cardiac and Endovascular Surgery, and Brazilian surgeons, with the return of the South Brazilian Congress of Cardiovascular Surgery.

We are waiting to welcome you, to this great meeting, with the well-known Brazilian hospitality.

Rui M. S. Almeida
President of 31st CWSCTS 2023

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。